Autopsy report · NCT05845125
Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone
Cause of deathFunding or business, also staffing, sites or logistics
“The decision to discontinue the project is based on several factors, including organizational constraints, lack of funding, and insufficient participant interest in taking part.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year before it stopped.
- 50 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Claire Bourgeois
- Sponsor type
- Government (non-US federal)
- Conditions
- Shoulder Pain
- Interventions
- Physiotherapy alone; Glenohumeral injection of 40mg (1cc) of Triamcinolone and 7cc of 0.5% Bupivacaine coupled with physiotherapy
- Participants
- 50
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
“Sponsor decided to discontinue the study due to strategic considerations and not due to any safety-related concerns.” - Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
“It was decided to discontinue the study due to insufficient recruitment.” - A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery
“Sponsor decision to discontinue study due to inability to recruit the expected number of subjects within the requisite time period.” - Treatment of ppROM With Erythromycin vs. Azithromycin Trial
“Patient population that meets study criteria is insufficient to continue project in a reasonable amount of time. To continue is futile in resources, staff time, and effort.” - The Dallas Hereditary Spherocytosis Cohort Study
“Insufficient staff to continue pursuing project”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.